FTA:
Scientists have demonstrated for the first time that a single-dose, needleless Ebola vaccine given to primates through their noses and lungs protected them against infection for at least 21 weeks.
A single-dose of an Ebola vaccine given to primates through their noses and lungs protected them against infection for at least 21 weeks.
www.sciencedaily.com
Unlock the Science Digest — our exclusive biweekly newsletter featuring the latest scientific discoveries, concise summaries, and Rhonda's expert commentary. Available only to FoundMyFitness Premium Members.
Choose a monthly subscription in
any eligible amount